Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct Growth vs Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment
NAV, returns and costs — not a recommendation.
 Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct Growth | Aditya Birla Sunlife Life Pharma and Healthcare Fund Direct IDCW Reinvestment | |
|---|---|---|
| NAV | ₹40.48 | ₹26.32 |
| NAV date | 2026-09-29 | 2026-09-29 |
| 1 year | +18.99% | +11.92% |
| 3 year (p.a.) | +20.42% | +15.14% |
| 5 year (p.a.) | +14.04% | +8.05% |
| Expense ratio | 0.84% | 0.84% |
| Fund size | ₹1,102.73 Cr | ₹950.31 Cr |
| Risk | Very high | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.